Skip to main content
. Author manuscript; available in PMC: 2022 May 31.
Published in final edited form as: Subst Use Misuse. 2021 Jul 29;56(12):1807–1814. doi: 10.1080/10826084.2021.1954026

Table 2.

Unadjusted and adjusted odds ratios for depressive and anxiety symptoms among dual and poly-users (n = 1736).

Depressive symptoms Anxiety symptoms
uOR (95% CI) p-value aOR (95% CI) p-value uOR (95% CI) p-value aOR (95% CI) p-value
Relative ENDS vs. OTP use
 ENDS less often than OTP – – – – – – – –
 About the same amount 0.80 (0.57, 1.11) 0.18 0.97 (0.69, 1.38) 0.88 1.02 (0.73, 1.43) 0.89 1.34 (0.94, 1.92) 0.11
 ENDS more often than OTP 1.02 (0.82, 1.25) 0.89 1.38 (1.06, 1.80) 0.02 0.98 (0.79, 1.21) 0.83 1.37 (1.04, 1.79) 0.02
Same-day MTP use
 Never/rarely – – – – – – – –
 Some days 1.16 (0.94, 1.43) 0.18 1.01 (0.80, 1.28) 0.93 1.11 (0.90, 1.38) 0.33 0.97 (0.76, 1.23) 0.78
 Most or every day 1.15 (0.89, 1.49) 0.28 0.90 (0.67, 1.21) 0.50 1.14 (0.88, 1.49) 0.32 0.87 (0.65, 1.18) 0.39

Relative ENDS vs. OTP use was assessed with the following, “How often did you use ENDS compared to other tobacco products in the past 30 days?” Same-day MTP use was assessed with the following, “How often did you use more than one tobacco product on the same day in the past 30 days?” Adjusted models controlled for gender identity, sexual orientation, race/ethnicity, subjective financial situation, frequency of ENDS use, and frequency of OTP use.